Cannara Biotech Inc. (TSXV: LOVE)

Market Cap	67.51M
Revenue (ttm)	81.75M
Net Income (ttm)	6.44M
Shares Out	90.02M
EPS (ttm)	0.07
PE Ratio	10.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	126,428
Open	0.800
Previous Close	0.800
Day's Range	0.750 - 0.810
52-Week Range	0.520 - 1.040
Beta	1.08
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: LOVE

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.